The global market for Healthcare Contract Research Organization (CRO) is estimated at US$52.1 Billion in 2023 and is projected to reach US$74.9 Billion by 2030, growing at a CAGR of 5.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Healthcare Contract Research Organization (CRO) Market]( "Healthcare Contract Research Organization (CRO) Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Clinical CRO segment, which is expected to reach US$61.3 Billion by 2030 with a CAGR of a 5.4%. The Pre-Clinical CRO segment is also set to grow at 5.2% CAGR over the next 7 years.
- Regional Analysis: Gain insights into the U.S. market, estimated at $15.8 Billion in 2023, and China, forecasted to grow at an impressive 5% CAGR to reach $13.1 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Healthcare Contract Research Organization (CRO) Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Healthcare Contract Research Organization (CRO) Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Healthcare Contract Research Organization (CRO) Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Axcent Advanced Analytics (A3), BIO Agile Therapeutics, Charles River Laboratories, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 33 Featured):
- Axcent Advanced Analytics (A3)
- BIO Agile Therapeutics
- Charles River Laboratories
- Covance, Inc.
- Firma Clinical Research
- GVK Biosciences Private Limited
- ICON, plc.
- IQVIA
- Medidata Solutions, Inc.
- Medpace Holdings
- Paraxel International
- Pharmaceutical Product Development, LLC (PPD)
- Pharmaron
- PPD
- PRA Health Sciences
- PSI CRO AG
- SGS
- Syneos Health
MarketGlass Platform
Our reports are enhanced by the MarketGlass platform, which brings together industry experts and influencers to provide high-quality, accurate insights. This unique platform allows us to gather comprehensive data and market perspectives, ensuring you receive the most reliable and detailed analysis available.Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERS3. MARKET TRENDS & DRIVERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Global Economic Update
- Healthcare Contract Research Organization (CRO) - Global Key Competitors Percentage Market Share in 2024 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 2: World Historic Review for Healthcare Contract Research Organization (CRO) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 3: World 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- Table 4: World Recent Past, Current & Future Analysis for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 5: World Historic Review for Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 6: World 16-Year Perspective for Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 8: World Historic Review for Pre-Clinical by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 9: World 16-Year Perspective for Pre-Clinical by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 10: World Recent Past, Current & Future Analysis for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 11: World Historic Review for Drug Discovery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 12: World 16-Year Perspective for Drug Discovery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Clinical Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 14: World Historic Review for Clinical Monitoring by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 15: World 16-Year Perspective for Clinical Monitoring by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 16: World Recent Past, Current & Future Analysis for Quality Management / Assurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 17: World Historic Review for Quality Management / Assurance by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 18: World 16-Year Perspective for Quality Management / Assurance by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Project Management / Clinical Supply Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 20: World Historic Review for Project Management / Clinical Supply Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 21: World 16-Year Perspective for Project Management / Clinical Supply Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 22: World Recent Past, Current & Future Analysis for Regulatory / Medical Affairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 23: World Historic Review for Regulatory / Medical Affairs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 24: World 16-Year Perspective for Regulatory / Medical Affairs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 25: World Recent Past, Current & Future Analysis for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 26: World Historic Review for Other Service Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 27: World 16-Year Perspective for Other Service Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- Table 28: World Healthcare Contract Research Organization (CRO) Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
UNITED STATES
- Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- Table 29: USA Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 30: USA Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 31: USA 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
- Table 32: USA Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 33: USA Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 34: USA 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
CANADA
- Table 35: Canada Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 36: Canada Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 37: Canada 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
- Table 38: Canada Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 39: Canada Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 40: Canada 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
JAPAN
- Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- Table 41: Japan Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 42: Japan Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 43: Japan 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
- Table 44: Japan Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 45: Japan Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 46: Japan 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
CHINA
- Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- Table 47: China Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 48: China Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 49: China 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
- Table 50: China Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 51: China Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 52: China 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
EUROPE
- Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- Table 53: Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2023 through 2030 and % CAGR
- Table 54: Europe Historic Review for Healthcare Contract Research Organization (CRO) by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 55: Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- Table 56: Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 57: Europe Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 58: Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
- Table 59: Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 60: Europe Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 61: Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
FRANCE
- Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- Table 62: France Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 63: France Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 64: France 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
- Table 65: France Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 66: France Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 67: France 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
GERMANY
- Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- Table 68: Germany Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 69: Germany Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 70: Germany 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
- Table 71: Germany Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 72: Germany Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 73: Germany 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
ITALY
- Table 74: Italy Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 75: Italy Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 76: Italy 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
- Table 77: Italy Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 78: Italy Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 79: Italy 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- Table 80: UK Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 81: UK Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 82: UK 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
- Table 83: UK Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 84: UK Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 85: UK 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
REST OF EUROPE
- Table 86: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 87: Rest of Europe Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 88: Rest of Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
- Table 89: Rest of Europe Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 90: Rest of Europe Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 91: Rest of Europe 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Healthcare Contract Research Organization (CRO) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- Table 92: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 93: Asia-Pacific Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 94: Asia-Pacific 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
- Table 95: Asia-Pacific Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 96: Asia-Pacific Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 97: Asia-Pacific 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
REST OF WORLD
- Table 98: Rest of World Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 99: Rest of World Historic Review for Healthcare Contract Research Organization (CRO) by Type - Clinical, Pre-Clinical and Drug Discovery Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 100: Rest of World 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Type - Percentage Breakdown of Value Sales for Clinical, Pre-Clinical and Drug Discovery for the Years 2014, 2024 & 2030
- Table 101: Rest of World Recent Past, Current & Future Analysis for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types - Independent Analysis of Annual Sales in US$ Million for the Years 2023 through 2030 and % CAGR
- Table 102: Rest of World Historic Review for Healthcare Contract Research Organization (CRO) by Service Type - Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2022 and % CAGR
- Table 103: Rest of World 16-Year Perspective for Healthcare Contract Research Organization (CRO) by Service Type - Percentage Breakdown of Value Sales for Clinical Monitoring, Quality Management / Assurance, Project Management / Clinical Supply Management, Regulatory / Medical Affairs and Other Service Types for the Years 2014, 2024 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Axcent Advanced Analytics (A3)
- BIO Agile Therapeutics
- Charles River Laboratories
- Covance, Inc.
- Firma Clinical Research
- GVK Biosciences Private Limited
- ICON, plc.
- IQVIA
- Medidata Solutions, Inc.
- Medpace Holdings
- Paraxel International
- Pharmaceutical Product Development, LLC (PPD)
- Pharmaron
- PPD
- PRA Health Sciences
- PSI CRO AG
- SGS
- Syneos Health
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 89 |
| Published | May 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 52.1 Billion |
| Forecasted Market Value ( USD | $ 74.9 Billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
